Get started
Author

Sibel Oyucu Orhan

Observed names: OYUCU ORHAN, SİBEL, Orhan Oyucu, Sibel, S.O. Orhan, Sibel O Orhan, Sibel O. Orhan, Sibel ORHAN, Sibel OYUCU ORHAN, Sibel Orhan
Observed institutions: Bursa Uludağ Üni̇versi̇tesi̇, Fırat University, Dokuz Eylül University, Antalya Eğitim ve Araştırma Hastanesi, Sağlık Bilimleri Üniversitesi, Bursa City Hospital
ORCID: 0000-0001-8217-3471
Observed ORCIDs: 0000-0001-8217-3471, 0000-0002-9845-6289
OpenAlex ID: A5101809371
Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy
2021 · Ahmet Bilgehan Şahin, Erdem Cubukcu, et al. · Scientific Reports · 133
PDF
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
2023 · Seda Kahraman, Enes Erul, et al. · Future Oncology · 27
The impact of Ki-67 index, squamous differentiation and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer
2021 · Birol Ocak, Fatma Öz Atalay, et al. · Bosnian Journal of Basic Medical Sciences · 13
Immunotherapy experience in sinonasal NUT midline carcinoma, case report
2023 · Burcu Caner, Sibel O. Orhan, et al. · Journal of Cancer Research and Therapeutics · 11
Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data
2021 · Sibel Oyucu Orhan, Ahmet Bilgehan Sahin, et al. · Bosnian Journal of Basic Medical Sciences · 9
PDF
Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment
2023 · Ahmet Sahin, Burcu Caner, et al. · Oncology Letters · 8
PDF
The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans
2020 · Deligonul Adem, Serkan Yazici, et al. · Bosnian Journal of Basic Medical Sciences · 8
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
2025 · Seda Kahraman, Enes Erul, et al. · Clinical Breast Cancer · 7
Managing Bone Metastases with Denosumab: Real-World Data and Critical Monitoring Points in Breast, Lung, and Prostate Cancers
2025 · Sibel Oyucu Orhan, Bedrettin Orhan, et al. · Medicina · 5
PDF
The Effect of Acute Phase Reactants on the Survival of COVID-19 Patients in Intensive Care
2021 · Sibel Oyucu Orhan, B. B. T. Mecit, et al. · Progress in nutrition · 4
PDF
Prognostic Value of Histological Subtypes and Clinical Factors in Non-Endemic Nasopharyngeal Carcinoma: A Retrospective Cohort Study
2025 · Seda Sali, Candan Demiröz Abakay, et al. · Medicina · 3
PDF
Octreotide ameliorates dermal fibrosis in bleomycin-induced scleroderma
2018 · Sibel OYUCU ORHAN, Ahmet TEKTEMUR, et al. · TURKISH JOURNAL OF MEDICAL SCIENCES · 3
Evaluation of the Frequency of Sleep Disorders, Depression and Anxiety in Patients with Early-Stage Breast Cancer: Cross-Sectional Study
2023 · Hülya ERTAŞ, Burcu CANER, et al. · Turkiye Klinikleri Journal of Medical Sciences · 2
PDF
Platin‑based chemotherapy does not improve survival in patients with non‑metastatic resected typical carcinoid tumors
2022 · Ahmet Sahin, Huseyin Melek, et al. · Molecular and Clinical Oncology · 2
PDF
Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer—Insights from a Systematic Review and Real-World Experience
2026 · Sibel Oyucu Orhan, Bedrettin Orhan, et al. · Journal of Clinical Medicine · 1
PDF
HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy
2025 · Seda Kahraman, Mutlu Hızal, et al. · Turkish Journal of Clinics and Laboratory · 1
PDF
Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast
2025 · Seda Sali, Mursel Sali, et al. · The Oncologist · 1
PDF
Survival Outcomes in Metaplastic Versus Triple-Negative Invasive Breast Carcinoma: A Propensity Score-Matched Study
2026 · Burcu Caner, Hulya Ertas, et al. · Medicina
Prognostic Value of Immunonutritional Status and Radiologic Muscle Mass in Older Patients Receiving Immune Checkpoint Inhibitors: A Real-World Study
2026 · Hülya Ertaş, Burcu Caner, et al. · Current Oncology
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study ( TOG / GI ‐ SAFRADJU ‐2501)
2026 · Erman Akkus, Mehmet Kayaalp, et al. · International Journal of Cancer
Beyond conventional staging: prognostic significance of systemic inflammatory indices at diagnosis in malignant peripheral nerve sheath tumors
2026 · Sibel Oyucu Orhan, Bedrettin Orhan, et al. · Turkish Journal of Clinics and Laboratory
Long-Term Survival of Cancer Patients Following COVID-19 Infection: Prognostic Value of Inflammatory Indices and Vaccination Status
2026 · Seda Sali, Mehmet Akif Ötegeçeli, et al. · Uludağ Üniversitesi Tıp Fakültesi Dergisi
PDF
Integrating Tumor Biology and Host Factors in mCRPC: The Prognostic Value of ‘Time to Castration Resistance’, Systemic Inflammation, and Comorbidity Burden in Patients Treated with Enzalutamide
2026 · Seda Sali, Arife Ulaş, et al. · Diagnostics
PDF
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO)
2026 · Erman Akkus, Mehmet Kayaalp, et al. · JCO Global Oncology
Optimizing Patient Selection for Bevacizumab Plus Irinotecan in Recurrent High Grade Glioma: Superiority of the Neutrophil-to-Lymphocyte Ratio Over Other Systemic Inflammation Indices
2026 · Sibel Oyucu Orhan, Bedrettin Orhan, et al. · Eurasian Journal of Medical Investigation
Works count: 42
Citation count: 238
H-index: 7
I10-index: 4
Year
Topic
Type